Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy

Haematologica. 2008 Apr;93(4):639-40. doi: 10.3324/haematol.11149.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Aplastic / complications
  • Anemia, Aplastic / surgery
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use*
  • Candida / classification
  • Candida / isolation & purification*
  • Candidiasis / etiology*
  • Candidiasis / microbiology
  • Candidiasis / prevention & control
  • Caspofungin
  • Echinocandins / administration & dosage
  • Echinocandins / therapeutic use*
  • Fluconazole / administration & dosage
  • Fluconazole / therapeutic use
  • Fungemia / etiology*
  • Fungemia / microbiology
  • Fungemia / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lipopeptides
  • Lymphoma, Non-Hodgkin / complications
  • Lymphoma, Non-Hodgkin / surgery
  • Male
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery
  • Premedication
  • Retrospective Studies
  • Transplantation, Homologous
  • Treatment Failure

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Fluconazole
  • Caspofungin